Altis Biosystems

About:

Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries.

Website: https://www.altisbiosystems.com/

Top Investors: Triangle Tweener Fund, Hatteras Venture Partners, VentureSouth, Central Texas Angel Network, Johnson Venture Partners

Description:

Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. Their organ on a chip product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modeling, precision medicine, microbiome research, and compound screening.

Total Funding Amount:

$4.54M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)AltisBiosystems.com

Founders:

Christopher Sims, Michael Biron, Nancy Allbritton, Scott Magness

Number of Employees:

11-50

Last Funding Date:

2024-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai